Page 12 - Erik Manting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 23, 2023

Corey davisErik mantingMario brkuljSwedish companies registration officeValency communicationsNegma groupLifesci advisorsSci advisorsMendus ab publ stock exchangePress releaseOnvertible immu se0005003654

Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023

Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMario brkuljErik mantingCorey davisClinical research excluding trialsAmerican association for cancer researchLifesci advisorsValency communicationsAmerican associationCancer researchAnnual meetingJeroen roversChief medical officerHigh grade serous ovarian cancerImmunomodulatory agentsNasdaq stockholm

Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group

07.03.2023 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has closed a second loan under the terms of the commitment from its largest shareholder Van Herk .

Mario brkuljErik mantingCorey davisLotta fermLifesci advisorsNegma groupValency communicationsChief financial officerVan herk investmentsAbuse regulationSci advisorsMendus ab

Mendus AB: Change in number of shares and votes in Mendus AB (publ)

Mendus AB: Change in number of shares and votes in Mendus AB (publ)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mario brkuljErik mantingCorey davisNegma groupLifesci advisorsValency communicationsWall streetSwedish financial instruments trading actSci advisorsNasdaq stockholm

Mendus AB: Live webcast to discuss clinical results of ADVANCE II trial presented at ASH 2022

07.12.2022 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will host a live webcast to review the Company’s most recent clinical results of the ADVANCE II trial in AML maintenance, which .

Mario brkuljErik mantingCorey davisLifesci advisorsValency communicationsSci advisorsMendus ab